Carbapenem-resistant Acinetobacter baumannii complex in the United States-An epidemiological and molecular description of isolates collected through the Emerging Infections Program, 2019.
Sandra N BulensDavina CampbellSusannah L McKayNicholas VlachosAlex BurginMark BurroughsJasmine PadilaJulian E GrassJesse T JacobGillian SmithDaniel B MuletaMeghan MaloneyBobbie MacierowskiLucy E WilsonElisabeth VaethRuth LynfieldSean O'MalleyPaula M Snippes VagnoneJennifer DaleSarah J JanelleChristopher A CzajaHelen JohnsonErin C PhippsKristina G FloresGhinwa DumyatiRebecca TsayZintars G BeldavsP Maureen CassidyAmanda HallMaroya S WaltersAlice Y GuhShelley S MagillJoseph D LutgringPublished in: American journal of infection control (2024)
Our surveillance found that CRAB isolates in the U.S. commonly harbor an aCP, have an antimicrobial susceptibility profile that is defined as difficult-to-treat resistance, and epidemiologically are similar regardless of the presence of an aCP.